Global push to tackle maternal and newborn deaths has stalled, WHO report finds
(Reuters) – Progress in reducing deaths during pregnancy and childbirth and among newborn infants has stalled since 2015, and over…
Health
Abortion providers sue to preserve, expand access to abortion pill
By Brendan Pierson (Reuters) – A group of abortion providers on Monday filed a lawsuit aiming to preserve access to…
Abortion pill case to be heard by conservative, anti-abortion panel
By Brendan Pierson and Jacqueline Thomsen (Reuters) – A case brought by anti-abortion groups seeking to ban the abortion pill…
After weight loss, Alzheimer’s may be next frontier for drugs like Ozempic
By Natalie Grover LONDON (Reuters) – Diabetes drugs that also promote weight loss such as Novo Nordisk’s Ozempic, becoming a…
Unhappy return: Sudan crisis forces South Sudanese refugees back to troubled home
By Denis Elamu RENK, South Sudan (Reuters) – The last place Lina Mijok wanted to go as she fled fighting…
WHO declares end to COVID global health emergency
By Jennifer Rigby and Bhanvi Satija LONDON (Reuters) -The World Health Organization ended the global emergency status for COVID-19 on…
North Carolina’s Republican-led legislature passes 12-week abortion ban
By Julia Harte and Joseph Ax (Reuters) -North Carolina’s Republican-controlled legislature passed a bill on Thursday that limits the window…
US FDA approves first RSV vaccine from GSK
(Reuters) -The U.S. Food and Drug Administration has approved GSK Plc’s respiratory syncytial virus (RSV) vaccine, the British drugmaker said…
Novo Nordisk rivals see room to compete in $100 billion weight-loss drug market
By Michael Erman NEW YORK (Reuters) – The enormous demand for weight-loss treatments like Novo Nordisk’s Wegovy could support as…
Lilly drug slows Alzheimer’s by 35%, bolstering treatment approach
By Julie Steenhuysen and Deena Beasley CHICAGO (Reuters) -An experimental Alzheimer’s drug developed by Eli Lilly and Co slowed cognitive…